Cytochrome c reduction by nalidixic and piromidic acids.
D000818:Animals; D003574:Cytochrome c Group / Q000032:analysis; D004579:Electron Transport; D006088:Gram-Negative Aerobic Bacteria / Q000187:drug effects; D006736:Horses; D007700:Kinetics; D009206:Myocardium / Q000201:enzymology; D009268:Nalidixic Acid / Q000494:pharmacology; D009539:Nicotinic Acids / Q000494:pharmacology; D010084:Oxidation-Reduction; D010618:Phenanthrolines / Q000494:pharmacology; D011759:Pyrrolidines / Q000494:pharmacology
D003574:Cytochrome c Group; D009539:Nicotinic Acids; D010618:Phenanthrolines; D011759:Pyrrolidines; D009268:Nalidixic Acid